about
Genetic dissection of complex genetic factor involved in NIDDM of OLETF ratDiabetic complications in obese type 2 diabetic rat modelsGender differences in metabolic disorders and related diseases in Spontaneously Diabetic Torii-Lepr(fa) rats.JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, reduces food preference for fat.Pharmacological effects of JTT-551, a novel protein tyrosine phosphatase 1B inhibitor, in diet-induced obesity miceDistribution of allele frequencies at TTN g.231054C > T, RPL27A g.3109537C > T and AKIRIN2 c.*188G > A between Japanese Black and four other cattle breeds with differing historical selection for marbling.Effects of unilateral nephrectomy on renal function in male Spontaneously Diabetic Torii fatty rats: a novel obese type 2 diabetic modelOcular inflammation in uveal tract in aged obese type 2 diabetic rats (Spontaneously Diabetic Torii fatty rats)Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizinAssociation of the expression levels in the longissimus muscle and a SNP in the CDC10 gene with marbling in Japanese Black beef cattle.Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesionsMaternal high-fat diet promotes onset of diabetes in rat offspring.The spontaneously diabetic torii rat: an animal model of nonobese type 2 diabetes with severe diabetic complications.Association of a single nucleotide polymorphism in akirin 2 gene with marbling in Japanese Black beef cattle.Effect of food restriction on adipose tissue in spontaneously diabetic Torii fatty rats.Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic ratJTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic ratsHepatocellular adenoma with severe fatty change in a male Spontaneously Diabetic Torii rat.JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage.Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.Effects of ovariectomy on bone metabolism and bone mineral density in spontaneously diabetic Torii-Lepr(fa) rats.Characterization of hepatic glucose metabolism disorder with the progress of diabetes in male Spontaneously Diabetic Torii rats.Association of a single-nucleotide polymorphism in myosin-binding protein C, slow-type (MYBPC1) gene with marbling in Japanese Black beef cattle.JTE-852, a novel spleen tyrosine kinase inhibitor, blocks immunoglobulin G-mediated cellular responses and autoimmune reactions in vivo.Daily inhibition of postprandial hyperglycaemia with JTT-608, a novel oral antidiabetic agent, ameliorates pancreatic function in neonatally streptozotocin-treated rats.JTP-103237, a novel monoacylglycerol acyltransferase inhibitor, modulates fat absorption and prevents diet-induced obesity.Pathophysiological profiles of SDT fatty rats, a potential new diabetic peripheral neuropathy model.Effects of food restriction on pancreatic islets in Spontaneously Diabetic Torii fatty rats.Effects on Glycemic Control in Impaired Wound Healing in Spontaneously Diabetic Torii (SDT) Fatty Rats.JTE-852, a novel spleen tyrosine kinase inhibitor, blocks antigen-induced allergic reactions in rats.JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis.Assessment of Pharmacological Responses to an Anti-diabetic Drug in a New Obese Type 2 Diabetic Rat Model.Identification of genes showing differential expression profile associated with growth rate in skeletal muscle tissue of Landrace weanling pig.Pathophysiological analysis of the progression of hepatic lesions in STAM mice.Physiological changes induced by salt intake in female Spontaneously Diabetic Torii-Lepr(fa) (SDT fatty) rat, a novel obese type 2 diabetic model.JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice.Blood pressure characteristics of female spontaneously diabetic Torii-Lepr(fa) rats.4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent.
P50
Q26809987-0B3DBFB6-644C-4694-BF17-34A7CF1FD02FQ26830284-737D2C6C-1856-415E-93CF-961BB081C771Q33661311-02C96519-57BC-48D6-A1D9-4FEC6EF8D171Q33737233-9488275E-765E-4D8D-8D99-57B5BA4668E3Q33766851-10BCC968-B3A0-4887-A8BB-EFE8E419EF11Q33798746-CE6F3364-21E0-44AF-A94D-3613CB6A8BE0Q34081116-BDBC5E5B-3B7E-4E34-9ABF-22EC15FA5A84Q34267618-37B5C9F0-4184-4152-B7E5-3AFDB74DAF0EQ35594390-D551F12A-5C28-43E2-B09D-268EB8F33FADQ35641784-477E0FF2-2600-4052-AE34-2BF6529B6F2AQ35942391-72AB01DA-0F4D-4657-8918-9FE2D524737AQ36008572-D34E2D05-EA7D-4C54-A530-CFE5424C619AQ36825739-D9E35AF2-F51D-4ED8-9AF2-43FDFA72A2C8Q37274146-62FFF1B2-9BF6-4D1C-80F0-1BEF9CBDB826Q37310950-D1797C15-52D2-4CB3-B3A3-0FEC9C6130EEQ38344984-CA3092A3-107E-4F04-8766-FFE658F878C7Q38628118-8CAAA1B5-DB05-4013-87FA-777BAE52FED3Q39936507-7EA8B974-E785-4216-8656-15F3C013DA3BQ42323664-1C045993-BE71-405C-AEF2-7F7F263BEC0BQ43190955-3C3D6D02-7185-4088-8F42-E89C2222C820Q43298673-2C80CDC0-FB42-4356-B63A-717E00390082Q44582066-3449C2DB-D055-43B7-A821-B664D90DBAE7Q45092888-2F17B377-3EB5-41AF-A5B9-FA6DEEDCBCA1Q46213665-07241E5F-1E23-490C-A2F8-1E5321A23B12Q46248119-54AEE69B-33A0-4FFB-8883-D0812AF4CA75Q46278239-C71F5DCE-D94E-4D57-A410-F44E9B48AD19Q46623831-7E185BA7-C8C0-4CAB-897B-E7B89927404FQ46746239-EF9CCD83-E27E-479A-9018-A32C12077332Q47918753-66567DC2-5A22-41E9-9936-50D4001EC111Q48181343-6970992A-4EA2-4A44-AA72-1B7C8F9D3652Q49343374-3A6AC5B9-1E28-4616-9B0D-757D62C0CD54Q49635004-0AF8583D-1532-4D33-8B56-4DEBAC3A0944Q49982347-DDBA4F1E-C8A9-47A7-92D2-B2F28482D563Q50129534-B2A2C015-1AE4-46D1-B8F6-951D59438372Q50502186-25C8E447-C41D-4BC9-A5BD-40375B54C354Q50523944-58F973F2-5FDC-4AB0-AE24-CE28EBA5E543Q51157989-7B0837B0-DAEE-42CC-BB0B-51FDA95FBF6CQ51297341-A73DF068-9B80-4A81-917E-DC31251815C0Q51530122-CF677176-AB4D-4B0F-BC96-21C8EE165CF0Q51565866-BBE47193-E178-4FF2-9126-E78B52D83741
P50
description
researcher
@en
name
Takeshi Ohta
@en
Takeshi Ohta
@nl
type
label
Takeshi Ohta
@en
Takeshi Ohta
@nl
prefLabel
Takeshi Ohta
@en
Takeshi Ohta
@nl
P106
P31
P496
0000-0002-9573-3455